Adebrelimab Injection

DRUG10 trials

Conditions

Advanced Biliary Tract CancerAdvanced Solid TumorsAdvanced Urothelial CarcinomaAdvanced or Metastatic Non-small Cell Lung CancerColorectal CancerGastric CancerGastroesophageal-junction CancerOvarian Cancer

Phase 1

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

RecruitingNCT06512051

Shanghai Hengrui Pharmaceutical Co., Ltd.Advanced or Metastatic Non-small Cell Lung Cancer

Start: 2024-07-30End: 2026-10-31Target: 248Updated: 2025-12-23

A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma

RecruitingNCT06639347

Shanghai Hengrui Pharmaceutical Co., Ltd.Advanced Urothelial Carcinoma

Start: 2024-11-04End: 2027-05-31Target: 90Updated: 2024-11-18

A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors

RecruitingNCT06703177

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced Solid Tumors

Start: 2025-02-18End: 2027-07-01Target: 876Updated: 2025-12-03

A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer

RecruitingNCT06840002

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Ovarian Cancer

Start: 2025-03-18End: 2026-07-31Target: 150Updated: 2025-09-30

Phase 2

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

Not yet recruitingNCT06599775

Shanghai Zhongshan HospitalResectable Esophageal Squamous Cell Carcinoma

Start: 2024-10-31End: 2028-10-31Target: 42Updated: 2024-09-19

A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer

RecruitingNCT07071714

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Colorectal Cancer

Start: 2025-07-22End: 2031-10-01Target: 200Updated: 2026-03-18

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

RecruitingNCT07110571

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Gastric Cancer, Gastroesophageal-junction Cancer

Start: 2025-08-28End: 2027-05-31Target: 200Updated: 2026-01-09

Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

Not yet recruitingNCT07357532

Peking University Cancer Hospital & InstituteSmall Cell Lung Carcinoma

Start: 2026-01-31End: 2028-10-30Target: 44Updated: 2026-01-22

Phase 3

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

RecruitingNCT07229625

Suzhou Suncadia Biopharmaceuticals Co., Ltd.Advanced Biliary Tract Cancer

Start: 2026-01-21End: 2029-12-01Target: 604Updated: 2026-01-28

Unknown Phase

Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer

RecruitingNCT06480864

Yunpeng LiuSmall Cell Lung Cancer